News

The company will offer a generic version of semaglutide in the country after Novo Nordisk let its patent expire there. Hims & Hers Health (NYSE: HIMS) is a top telehealth stock that has been growing ...
Trump’s tariffs and the trade war continue to roil global markets. Follow along for live updates on the Dow, S&P 500 and Nasdaq.
Nvidia's valuation has risen dramatically over the last two years since generative artificial intelligence became a ...
For the upcoming report, consensus estimates project earnings of $1.40 per share on sales of $9.51 billion. These figures ...
A recall of potato chips due to the possible presence of an undeclared allergen has been issued the second-highest risk warning by the U.S. Food and Drug Administration ( FDA ). Saratoga Potato Chips ...
Pershing Square, led by Bill Ackman, recently acquired a big stake in Howard Hughes at a significant premium, signaling ...
Digging Into the Bargain Bin Investing in beaten-down stocks can be a savvy strategy for long-term wealth creation, as it ...
A Mizuho analyst isn’t ready to turn bullish just yet, but he abandoned his bearish call while writing that the company’s “recent execution and momentum is stunning.” ...
U.S. stock indexes are drifting around their record levels following a better-than-expected update on inflation. The S&P 500 ...
The proposed San Francisco skyscraper would be the tallest building in the United States outside of New York and Chicago.
Berkshire Hathaway's McLane Company has historically underperformed, but recent margin and profitability improvements are ...
Shares of Johnson & Johnson climbed 4.5% in morning trading, enough to pace the S&P 500 index's SPX gainers. They were also headed for the biggest one-day gain since they rallied 4.6% on May 1, 2024.